Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker LNC
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 5, 2026 | LNC Lincoln National Corporation | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 5, 2026 | LNC Lincoln National Corporation | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Aug 10, 2026 | LNC Lincoln National Corporation | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 10, 2026 | LNC Lincoln National Corporation | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Jul 30, 2026 | LNC Lincoln National Corporation | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jul 30, 2026 | LNC Lincoln National Corporation | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 29, 2026 | LNC Lincoln National Corporation | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 1, 2026 | LNC Lincoln National Corporation | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 7, 2026 | LNC Lincoln National Corporation | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 7, 2026 | LNC Lincoln National Corporation | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 16, 2026 | LNC Lincoln National Corporation | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Mar 31, 2026 | LNC Lincoln National Corporation | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Feb 12, 2026 | LNC Lincoln National Corporation | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 12, 2026 | LNC Lincoln National Corporation | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 10, 2025 | LNC Lincoln National Corporation | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 30, 2025 | LNC Lincoln National Corporation | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 30, 2025 | LNC Lincoln National Corporation | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 31, 2025 | LNC Lincoln National Corporation | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jul 31, 2025 | LNC Lincoln National Corporation | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| May 27, 2025 | LNC Lincoln National Corporation | 8.01 Other Events | 8-K | 8-K ↗ |
| May 23, 2025 | LNC Lincoln National Corporation | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 23, 2025 | LNC Lincoln National Corporation | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| May 23, 2025 | LNC Lincoln National Corporation | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| May 20, 2025 | LNC Lincoln National Corporation | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| May 12, 2025 | LNC Lincoln National Corporation | 8.01 Other Events | 8-K | 8-K ↗ |
| May 8, 2025 | LNC Lincoln National Corporation | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 8, 2025 | LNC Lincoln National Corporation | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 9, 2025 | LNC Lincoln National Corporation | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Apr 9, 2025 | LNC Lincoln National Corporation | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Mar 4, 2025 | LNC Lincoln National Corporation | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Mar 4, 2025 | LNC Lincoln National Corporation | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Feb 6, 2025 | LNC Lincoln National Corporation | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 6, 2025 | LNC Lincoln National Corporation | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 4, 2025 | LNC Lincoln National Corporation | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Feb 4, 2025 | LNC Lincoln National Corporation | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Oct 31, 2024 | LNC Lincoln National Corporation | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 31, 2024 | LNC Lincoln National Corporation | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
37 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:43 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances